Global Standardized Financials

218.57 -1.40(-0.64%)05/17/2024
Resmed Inc. (RMD)

Income Statement
(Values in USD Thousands)
 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30
Net Income300,492208,800219,422229,664
Revenue1,196,9801,162,801963,0371,122,057
Cost Of Revenue515,403515,867362,977504,671
gross Profit681,577646,934600,060617,386
Operating Expenses306,993307,612311,063331,150
Selling General and Administrative Expenses229,919222,155222,874240,687
Research and Development Expenses77,07473,88075,71078,144
Other Expenses-2,496-68612,47961
Cost And Expenses822,396823,479674,040835,821
Operating Income374,584275,094288,997275,267
Interest Income17,970
Income Tax Expense74,92950,65452,76947,137
Income Before Tax375,421259,454272,191276,801
Earning Per Share Basic2.041.421.491.56
Earning Per Share Diluted2.041.421.491.56
weighted Average Shares Outstanding146,959147,132147,075147,015
weighted Average Shares Outstanding (Diluted)147,450147,545147,486147,554
Gross Margin0.570.560.620.55
EBIT Margin0.360.390.300.30
Profit Margin0.250.180.230.20
EBITDA429,226456,920288,997333,761
Earning Before Tax Margin0.310.220.280.25